We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA, NIH, Drugmakers and Nonprofits Launch Gene Therapy Consortium for Rare Diseases
FDA, NIH, Drugmakers and Nonprofits Launch Gene Therapy Consortium for Rare Diseases
The FDA has teamed up with the National Institutes of Health (NIH), 10 pharmaceutical companies and five nonprofit organizations to launch the Bespoke Gene Therapy Consortium to accelerate development of gene therapies for rare diseases.